Imunon, Inc. Accounts Payable, Trade, Current
Imunon, Inc. (IMNN) had Accounts Payable, Trade, Current of $1.62 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableTradeCurrent · last filed 2026-08-11
- 2026-06-30: Accounts Payable, Trade, Current $1.62M.
- 2026-03-31: Accounts Payable, Trade, Current $964.59K.
- 2025-12-31: Accounts Payable, Trade, Current $1.39M.
- 2025-09-30: Accounts Payable, Trade, Current $1.13M.
| Period end | Accounts Payable, Trade, Current |
|---|---|
| 2026-06-30 | $1.62M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $964.59K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $1.39M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $1.13M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.74M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $1.86M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.30M 10-K · filed 2026-03-31 |
| 2024-09-30 | $2.36M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.97M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.36M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $3.52M 10-K · filed 2025-02-27 |
| 2023-09-30 | $1.83M 10-Q · filed 2023-11-14 |
| 2022-12-31 | $3.59M 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |